Skip to content

OX40/CD134 AVI3245G

by Biocare Medical, LLC

Ref AVI3245G

OX40/CD134 AVI3245G, a tumour necrosis factor receptor superfamily IVD (EU IVDD general IVD; FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Biocare Medical, LLC, was registered in EUDAMED on 28 Sep 2026 (Basic UDI-DI B-00847627026705) and listed in FDA GUDID on 7 Dec 2022 (UDI-DI 00847627026705); the registry lists it as withdrawn as of 24 Oct 2026.

Withdrawn Withdrawn in European Union.

Was authorized under CE IVDD, withdrawn

Ended

Withdrawn

Date not published (CE IVDD)

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627026705 Basic UDI-DI 00847627026705UDI-DIDate28 Sep 2026RegisteredStatusWithdrawn
United StatesGUDID listing GUDID Number00847627026705 UDI-DI Date7 Dec 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 24 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627026705 registered 28 Sep 2026 Withdrawn
  • FDA GUDID UDI-DI 00847627026705 listed 7 Dec 2022 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627026705
  2. Registered EUDAMED B-00847627026705

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Withdrawn
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
OX40/CD134
Generic name
Tumour necrosis factor receptor superfamily IVD, antibody
Model / reference
AVI3245G
Primary DI / UDI-DI
00847627026705 EUDAMED
00847627025272 GUDID
Basic UDI-DI
B-00847627026705
FDA product code
NJT
EMDN code
W0102039099 Tumour markers - other
GMDN term
Tumour necrosis factor receptor superfamily IVD, antibody
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.1860
EU registration type
Legacy device (under a directive)
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Primary DI / UDI-DIEUDAMED
00847627026705
GUDID
00847627025272
Device classEUDAMED
Class IVD General
GUDID
Class I

The registries describe this device under different primary UDI-DIs (EUDAMED lists 00847627026705; FDA GUDID lists 00847627025272), so their flags are not compared. Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under TUMOUR MARKERS - OTHER.

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)